CARRERO ET AL.: 'Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program.' J. NUTR. vol. 137, 2007, pages 384 - 390, XP008148363 (B1)

YOKOYAMA ET AL.: 'Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis.' LANCET vol. 369, 2007, pages 1090 - 98, XP022009572 (B1)

CONTACOS ET AL.: 'Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.' ARTERIOSCLER THROMB VASC BIOL vol. 13, 1993, pages 1755 - 1762, XP009016030 (B1)

DURRINGTON, P.N. ET AL.: "An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia", HEART, vol. 85, 2001, pages 544-548, XP002685560, (B1)

FOR THE JAPAN EPA LIPID INTERVENTION STUDY (JELIS) INVESTIGATORS YOKOYAMA ET AL: "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis", THE LANCET, LANCET LIMITED. LONDON, GB, vol. 369, no. 9567, 30 March 2007 (2007-03-30), pages 1090-1098, XP022009572, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(07)60527-3 (B1)

HOSKINS ET AL.: 'Combination use of statins and omega-3 fatty acids: an emerging therapy for combined hyperlipidemia.' FUTURE LIPIDOLOGY vol. 1, no. 5, 2006, pages 579 - 591 (B1)

JACOBSON ET AL.: 'Hypertriglyceridemia and Cardiovascular Risk Reduction.' CLINICAL THERAPEUTICS vol. 29, no. 5, 2007, pages 763 - 777, XP022194341 (B1)

NAKAMURA N ET AL: "Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia", INTERNATIONAL JOURNAL OF CLINICAL AND LABORATORY RESEARCH, SPRINGER, BERLIN, DE, vol. 29, no. 1, 1 March 1999 (1999-03-01), pages 22-25, XP002558875, ISSN: 0940-5437, DOI: 10.1007/S005990050057 (B1)

RAMBJOR G S ET AL: "EICOSAPENTAENOIC ACID IS PRIMARILY RESPONSIBLE FOR HYPOTRIGLYCERIDEMIC EFFECT OF FISH OIL IN HUMANS", LIPIDS, SPRINGER, US, vol. 31, no. 3, SUPPL, 1 January 1996 (1996-01-01), pages S45-S49, XP000614874, ISSN: 0024-4201, DOI: 10.1007/BF02637050 (B1)

STARK ET AL.: 'Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy.' AM J CLIN NUTR vol. 79, 2004, pages 765 - 73, XP008148360 (B1)

US-A1- 2006 135 610 (B1)

US-A1- 2007 191 467 (B1)

US-A1- 2008 125 490 (B1)

VASUDEVAN ET AL.: 'Effective Use of Combination Lipid Therapy.' CURRENT ATHEROSCLEROSIS REPORTS vol. 8, 2006, pages 76 - 84, XP008115780 (B1)

WO-A1-2008/004900 (B1)

WO-A1-2008/045465 (B1)

WO-A2-00/44361 (B1)

CHAN ET AL.: 'Effect of Atorvastatin and Fish Oil on PlasmaHigh-Sensitivity C-Reactive Protein Concentrations in Individuals with Visceral Obesity.' CLINICAL CHEMISTRY vol. 48, no. 6, 2002, pages 877 - 883, XP008148352 (B1)